These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25070616)

  • 21. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between HDL cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance.
    Bardini G; Dicembrini I; Rotella CM; Giannini S
    Acta Diabetol; 2013 Apr; 50(2):277-81. PubMed ID: 21997326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea.
    Mari A; Nielsen LL; Nanayakkara N; DeFronzo RA; Ferrannini E; Halseth A
    Horm Metab Res; 2006 Dec; 38(12):838-44. PubMed ID: 17163361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC; Miranda WL; Chacra AR; Dib SA
    J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hyperbolic equilibrium between insulin sensitivity and secretion.
    Pacini G
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S22-7. PubMed ID: 16530125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between beta-cell mass and diabetes onset.
    Matveyenko AV; Butler PC
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4(0 4):23-31. PubMed ID: 18834430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired pancreatic beta cell compensatory function is the main cause of type 2 diabetes in individuals with high genetic risk: a 9 year prospective cohort study in the Chinese population.
    Yan J; Peng D; Jiang F; Zhang R; Chen M; Wang T; Yan D; Wang S; Hou X; Bao Y; Hu C; Jia W
    Diabetologia; 2016 Jul; 59(7):1458-1462. PubMed ID: 27008621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoids and beta-cell function.
    Fichna M; Fichna P
    Endokrynol Pol; 2017; 68(5):568-573. PubMed ID: 29168546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defective Amplifying Pathway of β-Cell Secretory Response to Glucose in Type 2 Diabetes: Integrated Modeling of In Vitro and In Vivo Evidence.
    Grespan E; Giorgino T; Arslanian S; Natali A; Ferrannini E; Mari A
    Diabetes; 2018 Mar; 67(3):496-506. PubMed ID: 29229615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An examination of beta-cell function measures and their potential use for estimating beta-cell mass.
    Kahn SE; Carr DB; Faulenbach MV; Utzschneider KM
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():63-76. PubMed ID: 18834434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta cell function and its relation to insulin action in humans: a critical appraisal.
    Ferrannini E; Mari A
    Diabetologia; 2004 May; 47(5):943-56. PubMed ID: 15105990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptation of β-Cell and Endothelial Function to Carbohydrate Loading: Influence of Insulin Resistance.
    Hurwitz BE; Schneiderman N; Marks JB; Mendez AJ; Gonzalez A; Llabre MM; Smith SR; Bizzotto R; Santini E; Manca ML; Skyler JS; Mari A; Ferrannini E
    Diabetes; 2015 Jul; 64(7):2550-9. PubMed ID: 25754957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying beta cell function in the preclinical stages of type 1 diabetes.
    Galderisi A; Carr ALJ; Martino M; Taylor P; Senior P; Dayan C
    Diabetologia; 2023 Dec; 66(12):2189-2199. PubMed ID: 37712956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Over-nutrition, obesity and insulin resistance in the development of β-cell dysfunction.
    Gupta D; Krueger CB; Lastra G
    Curr Diabetes Rev; 2012 Mar; 8(2):76-83. PubMed ID: 22229253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes.
    Schofield CJ; Sutherland C
    Diabet Med; 2012 Aug; 29(8):972-9. PubMed ID: 22443306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-cell dysfunction in adolescents and adults with newly diagnosed type 2 diabetes mellitus.
    Elder DA; Herbers PM; Weis T; Standiford D; Woo JG; D'Alessio DA
    J Pediatr; 2012 Jun; 160(6):904-10. PubMed ID: 22240107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing the Concept of Type 2 Diabetes: Beta Cell Workload Hypothesis Revisited.
    Saisho Y
    Endocr Metab Immune Disord Drug Targets; 2019; 19(2):121-127. PubMed ID: 30173655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in diabetes for the millennium: understanding insulin resistance.
    Gerich JE; Dailey G
    MedGenMed; 2004 Aug; 6(3 Suppl):11. PubMed ID: 15647716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of insulin secretion in relation to insulin resistance.
    Mari A; Ahrén B; Pacini G
    Curr Opin Clin Nutr Metab Care; 2005 Sep; 8(5):529-33. PubMed ID: 16079624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-cell function assessment from modelling of oral tests: an effective approach.
    Mari A; Ferrannini E
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():77-87. PubMed ID: 18834435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.